Dr Anneke Blackburn is a group leader at the John Curtin School of Medical Research, The Australian National University, in Canberra. She completed her PhD in Medical Sciences at JCSMR in 1996, gained postdoctoral training in the Molecular Genetics Group at JCSMR, and in 1999 moved into breast cancer genetics research at the University of Massachusetts, Amherst, USA in the lab of Prof D. Joseph Jerry. This work lead to the identification of genetic factors involved in breast cancer susceptibility in mice. Upon return to JCSMR in 2002, with the support of a NHMRC Howard Florey Centenary Fellowship and R.D. Wright Career Development Award, Dr Blackburn worked to translate these findings to patient populations through familiar cancer consortia based in Australia, with the aim of identifying those people most at risk of developing cancer. Concurrently, her research team is examining novel treatments targeting cancer metabolism, particularly dichloroacetate, with the aim of improving the outcomes of cancer patients.